CIBC Private Wealth Group
AXSM icon

CIBC Private Wealth Group’s Axsome Therapeutics AXSM Stock Holding History

CIBC Private Wealth Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.86M Buy
15,684
+1,309
+9% +$183K ﹤0.01% 514
2025
Q3 		$1.75M Buy
14,375
+686
+5% +$77.3K ﹤0.01% 596
2025
Q2 		$1.43M Sell
13,689
-26
-0.2% -$2.75K ﹤0.01% 611
2025
Q1 		$1.34M Sell
13,715
-2,499
-15% -$285K ﹤0.01% 603
2024
Q4 		$1.34M Hold
16,214
– – ﹤0.01% 639
2024
Q3 		$1.46M Hold
16,214
– – ﹤0.01% 621
2024
Q2 		$1.36M Sell
16,214
-180
-1% -$13.3K ﹤0.01% 601
2024
Q1 		$1.26M Sell
16,394
-1,605
-9% -$135K ﹤0.01% 617
2023
Q4 		$1.43M Buy
17,999
+135
+0.8% +$9.03K ﹤0.01% 563
2023
Q3 		$1.25M Sell
17,864
-2,526
-12% -$189K ﹤0.01% 566
2023
Q2 		$1.47M Buy
20,390
+3,795
+23% +$280K ﹤0.01% 538
2023
Q1 		$1.02M Sell
16,595
-827
-5% -$54.3K ﹤0.01% 602
2022
Q4 		$1.34M Sell
17,422
-1,901
-10% -$114K ﹤0.01% 481
2022
Q3 		$862K Sell
19,323
-2,078
-10% -$104K ﹤0.01% 616
2022
Q2 		$820K Buy
21,401
+1,119
+6% +$35.4K ﹤0.01% 632
2022
Q1 		$839K Hold
20,282
– – ﹤0.01% 662
2021
Q4 		$766K Buy
20,282
+612
+3% +$22.5K ﹤0.01% 694
2021
Q3 		$648K Hold
19,670
– – ﹤0.01% 694
2021
Q2 		$1.33M Hold
19,670
– – ﹤0.01% 605
2021
Q1 		$1.11M Buy
19,670
+3,687
+23% +$259K ﹤0.01% 647
2020
Q4 		$1.3M Buy
15,983
+3,317
+26% +$248K ﹤0.01% 580
2020
Q3 		$902K Buy
+12,666
New +$987K ﹤0.01% 573

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Private Wealth Group's AXSM Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Axsome Therapeutics (AXSM) stake by 9.1% in Q4 2025, buying an estimated $183K and bringing the position to 15,684 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #514.

CIBC Private Wealth Group first reported a position in AXSM in Q3 2020 and has held it in 22 quarters since. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

  • CIBC Private Wealth Group held 15,684 shares of Axsome Therapeutics worth $2.86M as of Q4 2025.
  • CIBC Private Wealth Group bought 1,309 Axsome Therapeutics shares in Q4 2025, an estimated $183K.
  • Axsome Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #514 holding.
  • CIBC Private Wealth Group first reported a position in Axsome Therapeutics in Q3 2020 and has held it in 22 quarters since.
  • 398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.